- Home
- TRAK vs PRQR Comparison
TRAK vs PRQR Comparison
Compare TRAK & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRAK | PRQR |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.0M | 167.5M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TRAK | PRQR |
|---|---|---|
| Price | $7.51 | $1.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.80 |
| AVG Volume (30 Days) | 135.3K | ★ 366.8K |
| Earning Date | 05-14-2026 | 03-12-2026 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | ★ 20.69 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $21,007,076.00 | N/A |
| Revenue This Year | $6.61 | $18.88 |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | $42.22 | ★ N/A |
| Revenue Growth | ★ 4.84 | N/A |
| 52 Week Low | $6.94 | $1.08 |
| 52 Week High | $23.72 | $3.10 |
Technical Indicators
Market Signals| Indicator | TRAK | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 34.46 | 54.29 |
| Support Level | N/A | $1.33 |
| Resistance Level | $9.02 | $1.80 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 44.27 | 71.00 |
Price Performance
Historical ComparisonAbout TRAK ReposiTrak Inc.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.